Wide-ranging effects may result from this bottleneck, especially in therapeutic areas where there are unmet medical needs, lv appike in the case of rare diseases or ailments with few available treatments. Patients may have fewer options if new treatments for these conditions are developed slowly due to a lack of IND slots. promoting innovation in the pharmaceutical sector.
